Thermo Fisher Scientific Inc. (NYSE: TMO) is the world leader in serving science, with a mission to enable our customers to make the world healthier, cleaner, and safer. Whether our customers are driving life sciences research, addressing complex analytical challenges, or enhancing laboratory productivity, we provide a comprehensive range of technologies to support their work. With a strong emphasis on supporting cancer research and discovery, we offer complete workflow solutions that encompass pre-analytical needs such as nucleic acid, cell, exosome, and protein isolation, cell culture and transfection solutions down to robust analytical technologies for cell imaging, flow cytometry and cell sorting, protein detection, quantitative PCR, and digital PCR. Our commitment is to support our customers’ endeavors every step of the way. Our global team offers an unparalleled combination of innovative technologies and purchasing convenience through our industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon, and PPD. | PPD is now the Clinical Research Group (CRG) for Thermo Fisher Scientific, where our clinical development and analytical services enable customers to accelerate innovation and increase drug development productivity. Utilizing patient-centered strategies and data analytics, CRG’s capabilities cover multiple therapeutic areas and include early development, all phases of clinical development, peri- and post-approval, novel approaches to patient recruitment and investigator sites, and comprehensive laboratory services. Recognized as a global industry CRO leader in accelerating promising medicines from early development through regulatory approval and market access, CRG serves pharma, biotech, medical device and government organizations with custom-tailored solutions, including full-service partnerships and functional service partnerships. As a strategic partner in clinical development and analytical services, CRG applies cutting edge technologies, therapeutic expertise and a firm commitment to quality to help customers deliver life-changing therapies. | Thermo Fisher Scientific is the world leader in serving science. Our Mission is to enable our customers to make the world healthier, cleaner and safer. Through our Applied Biosystems and Ion Torrent brands, we offer an unmatched combination of innovative genomics products and services including real-time PCR, capillary electrophoresis, microarray, next generation sequencing technologies and consumables, purchasing convenience and support. | The PPD clinical research business of Thermo Fisher Scientific enable customers to accelerate innovation and increase drug development productivity. Utilizing patient-centered strategies and data analytics, our capabilities cover multiple therapeutic areas and include early development, all phases of clinical development, peri- and post-approval, novel approaches to patient recruitment and investigator sites, and comprehensive laboratory services. | Thermo Fisher Scientific™ is the world leader in serving science. Our mission is to enable our customers to make the world healthier, cleaner, and safer. With industry-leading chromatography, mass spectrometry, FTIR and Raman Spectroscopy workflows, we enable scientists to be on the leading edge of research. Whether you work in cutting-edge analytical research or routine analysis, we have the solutions to meet your needs. | Thermo Fisher Scientific is the world leader in serving science, with annual revenue of approximately $44 billion. Our Mission is to enable our customers to make the world healthier, cleaner and safer. Whether our customers are accelerating life sciences research, solving complex analytical challenges, increasing productivity in their laboratories, improving patient health through diagnostics or the development and manufacture of life-changing therapies, we are here to support them. Our global team delivers an unrivaled combination of innovative technologies, purchasing convenience and pharmaceutical services through our industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon and PPD. | Whether they are improving life for patients, protecting our global climate or keeping people safe, our customers look to Thermo Fisher Scientific for innovative solutions. Products and services sold under the following Thermo Fisher brands enable customers to push science and technology a step beyond. | x | Thermo Fisher Scientific is the world leader in serving science with a Mission of enabling its customers to make the world healthier, cleaner and safer. Thermo Fisher supports customers in accelerating life sciences research, solving complex analytical challenges, increasing productivity in their laboratories, improving patient health through diagnostics and developing and manufacturing of life-changing therapies. The company’s global team delivers an unrivaled combination of innovative technologies, purchasing convenience and pharmaceutical services through its industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon and PPD. For more information, please visit www.thermofisher.com. | Thermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue over $40 billion. Our Mission is to enable our customers to make the world healthier, cleaner and safer. Whether our customers are accelerating life sciences research, solving complex analytical challenges, increasing productivity in their laboratories, improving patient health through diagnostics or the development and manufacture of life-changing therapies, we are here to support them. Our global team delivers an unrivaled combination of innovative technologies, purchasing convenience and pharmaceutical services through our industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon and PPD. | Thermo Fisher Scientific is the world leader in serving science, delivering advanced analytical solutions from exploration to ore delivery. We help mining operators improve product quality, boost efficiency, reduce costs, and support safer, cleaner operations—while minimizing waste and environmental impact. Visit us at Booth 846 to connect with our experts and discover our latest solutions for process sampling and slurry analysis. Learn more at thermofisher.com/mineralsxrf. | Thermo Fisher Scientific supplies innovative solutions for the world’s law enforcement agencies. The Thermo Scientific™ TruNarc™ and 1064Defender™ narcotics analyzers can identify hundreds of narcotics, precursors or cutting agents, while our FBI NDIS approved* RapidHIT™ ID, enables law enforcement to use DNA information to solve cases in real time. | Thermo Fisher Scientific Inc. (NYSE: TMO) is the world leader in serving science, with annual revenue over $40 billion. Our Mission is to enable our customers to make the world healthier, cleaner and safer. Whether our customers are accelerating life sciences research, solving complex analytical challenges, increasing productivity in their laboratories, improving patient health through diagnostics or the development and manufacture of life-changing therapies, we are here to support them. Our global team delivers an unrivaled combination of innovative technologies, purchasing convenience and pharmaceutical services through our industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon and PPD. | Thermo Fisher Scientific is your trusted industry partner, offering comprehensive solutions for the challenges faced by mining and mineral operations. Our advanced technologies cover the entire mining process, enabling improved product quality, increased efficiency, cost reduction, and safer working environments. With our applied technology range comprising of XRF, XRD, PGNAA, and Spectroscopy systems we ensure the accurate identification of elements and compounds to optimize mining processes and extends quarry life. We prioritize regulatory compliance, ensuring our solutions meet industry standards and requirements. | Thermo Fisher Scientific is the world leader in serving science. Our mission is to enable our customers to make the world healthier, cleaner and safer. Through our Thermo Scientific brand, we help customers accelerate innovation and enhance productivity. Thermo Fisher Scientific supplies innovative solutions to the world’s polymers/plastics industry. With applications that span from Research & Development to Quality Control to Recycling we provide a broad range of products and services. | Thermo Fisher Scientific is the world leader in serving science. Our mission is to enable our customers to make the world healthier, cleaner, and safer. For more than 70 years, Thermo Scientific™ product inspection solutions and analytical for food, pharmaceutical, and consumer products have been helping companies protect the safety and quality of their packaged and unpackaged products. From the consistent accuracy of our checkweighers, to the sensitivity of our metal detectors, to the detection performance of our X-ray systems, our solutions are proven effective and expertly tailored to your application. Maximize uptime with a range of service and support options.Product Inspection EquipmentX-ray inspection: Our X-ray inspection systems provide complete protection from metal, glass, stone, and other dense foreign objects. Models range from our entry-level Thermo Scientific™ NextGuard™ X-ray system to our high-performance, flexible Thermo Scientific™ Xpert™ systems.Metal detection: Thermo Scientific metal detection systems provide a high level of performance, ease of use, and reliability. Our Thermo Scientific™ metal detector product family is designed to provide the highest level of sensitivity with minimal false rejections in a broad range of applications.Checkweighing: Thermo Scientific™ Versa checkweighers combine the latest in weighing technology with a variety of weighframes for general purpose food, pharmaceutical, and consumer products applications as well as multi-lane, high rate, and high accuracy applications.Combination systems: The Thermo Scientific™ combination systems are designed to provide a wide range of weighing and metal detection or x-ray inspection solutions.Analytical Instruments for Foreign Body InvestigationThermo Scientific™ FTIR instruments and handheld XRF analyzers help identify the makeup of debris found in food, enabling food processors to more quickly identify the source and resolve contamination issues.Handheld XRF analysis for pieces of metal, glass, stones, bones, rubber and hard plasticFTIR analysis to discriminate between polymers, small molecule organics and some inorganic compounds | Thermo Fisher Scientific is the world leader in serving science, with a mission to enable our customers to make the world healthier, cleaner, and safer. For over 70 years, our Thermo Scientific⢠product inspection and analytical solutions have helped food, pharmaceutical, and consumer goods manufacturers uphold the highest standards of product quality, safety, and regulatory compliance. Our technologies play a critical role in QA/QC programs by enabling precise detection, measurement, and analysis at multiple stages of production. From high-performance X-ray systems that identify dense contaminants, to sensitive and reliable metal detectors, to precision checkweighers that ensure accurate fill levelsâour solutions support consistent, repeatable quality outcomes. We also offer integrated combination systems that streamline inspection and weighing in a single footprint, improving operational efficiency. For root cause analysis and contamination investigation, our handheld XRF analyzers and FTIR spectrometers provide rapid, actionable insights into foreign material composition. Backed by a global service network and customizable support plans, Thermo Fisher Scientific helps maximize uptime across customer operations. Our UV-Vis spectrophotometers offer accurate and reliable measurements of absorbance and transmittance, essential for analyzing the purity and concentration of samples in various industries, aiding in research and development.Product Inspection Equipment:X-ray inspection: Our systems provide protection from metal, glass, stone, and other dense foreign objects, ranging from the entry-level Thermo Scientific⢠NextGuard⢠to the high-performance Thermo Scientific⢠Xpert⢠systems.Metal detection: Thermo Scientific metal detection systems offer high performance, ease of use, and reliability, designed for high sensitivity with minimal false rejections across various applications.Checkweighing: Thermo Scientific⢠Versa checkweighers combine advanced weighing technology with diverse weighframes for food, pharmaceutical, and consumer products applications, including multi-lane, high rate, and high accuracy needs.Combination systems: Thermo Scientific⢠combination systems provide integrated weighing and metal detection or X-ray inspection solutions.Analytical Instruments for Foreign Body Investigation:Handheld XRF analysis: Identifies metal, glass, stones, bones, rubber, and hard plastic.FTIR analysis: Discriminates between polymers, small molecule organics, and some inorganic compounds.UV-Vis Spectroscopy Instruments:GENESYS series: Offers robust performance and user-friendly features, valuable for laboratories in the food and beverage industry.Evolution series: Provides precise and reliable measurements for various applications in the food and beverage industry.Applications:Quality Control: Monitoring product quality and consistency by measuring absorbance to detect contaminants or ensure proper formulation.Nutrient Analysis: Determining the concentration of vitamins, minerals, and other nutrients in food and beverages.Color Measurement: Assessing product color for quality control and consumer appeal.Additive and Preservative Analysis: Measuring levels of additives and preservatives to ensure regulatory compliance. | Thermo Fisher Scientific is the world leader in serving science. Our mission is to enable our customers to make the world healthier, cleaner and safer. Lab scientists in manufacturing and research and development need advanced solutions. Our broad portfolio of solutions for polymer analysis, backed by a proven record of reliability and expertise, can help you deliver results. Whether you need to conduct chemical analysis, compounding and extrusion, elemental analysis, rheological analysis, or structural analysis to help ensure your products are meeting specifications, or if you are trying to develop new products, our solutions will help you drive innovation and productivity in polymer analysis. Learn more at thermofisher.com/polymer-analysis. | Thermo Fisher Scientific is the world leader in serving science, providing advanced analytical solutions for exploration to ore delivery that help mining operators and processors improve product quality, increase efficiency, reduce costs, and ensure safer, cleaner operations. We help: Researchers identify elements and extend the life of mining sites, Producers enhance efficiency and reduce environmental impact. Operators minimize waste and maximize profitability. Visit our booth 1410 to discover our latest technologies, attend presentations, and meet our team of experts who will be available to discuss your challenges. Learn more at www.thermofisher.com/mining
Taiwan Bio-Manufacturing Corporation (TBMC)
Enabling reliable development and manufacturing of advanced therapies and complex biologics through a next-generation CRDMO platform. Taiwan Bio-Manufacturing Corporation (TBMC) is a Taiwan-based pure-play CRDMO focused on supporting global pharmaceutical and biotechnology partners in advancing next-generation therapeutics. Built upon Taiwan’s strong biotechnology research foundation and world-class manufacturing ecosystem, TBMC integrates experienced GMP expertise with advanced production technologies. TBMC provides end-to-end CRDMO solutions across cell therapy, mRNA therapeutics, viral vectors, plasmid DNA, and complex biologics including ADCs and bispecific antibodies. With modular, flexible, and digital GMP facilities, strong IP protection, and an Asia-based manufacturing presence, TBMC enables global partners to accelerate development timelines, scale manufacturing capacity, and support regulatory compliance across international markets. Partner with TBMC to strengthen your global manufacturing strategy for next-generation therapies.
Taiwan Cell Manufacturing Co. Ltd
At Taiwan Cell Manufacturing Co. (tcmc), we specialize in delivering premium-quality lentiviral vectors (LVVs) and cell therapy products tailored to meet your needs. LVVs play an important role in genetic engineering of T cells, and we offer advanced solutions for LVV manufacturing to support gene-editing T cells, from R&D to full-scale commercialization. Our expertise also extends to the manufacturing of non-genetically modified cells as well, including DC, NK and stem cells. We understand the complex world of compliance, so every CDMO service we provide is accompanied by robust regulatory support for your CMC package. From groundbreaking research to life-changing therapies, tcmc is your trusted partner in developing next generation therapies.
SyVento BioTech
SyVento BioTech is an innovative biotech partner offering end-to-end capabilities to develop, formulate and manufacture next-generation mRNA-based products and innovative medicines. Leveraging unique know-how and customer-centric flexibility, the company delivers comprehensive services, including preclinical/clinical drug development, RUO/GMP-grade mRNA synthesis, manufacturing of GMP commercial/clinical batches, and aseptic fill & finish—all under one roof. With a state-of-the-art facility located in the EU (Poland), SyVento BioTech specializes in liposomal and LNP technology, providing tailored solutions for the encapsulation and delivery of therapeutic molecules, such as: RNA, DNA, CRISPR, small molecules, proteins and peptides. The company supports customers on each step of the project, including quality control, analytics, bioassay, regulatory support, warehousing and project management. | SyVento BioTech is an innovative biotech partner offering end-to-end capabilities to develop, formulate and manufacture next-generation mRNA-based products and innovative medicines. Leveraging unique know-how and customer-centric flexibility, the company delivers comprehensive services, including preclinical/clinical drug development, RUO/GMP-grade mRNA synthesis, manufacturing of GMP commercial/clinical batches, and aseptic fill & finish – all under one roof. With a state-of-the-art facility located in the EU (Poland), SyVento BioTech specializes in liposomal and LNP technology, providing tailored solutions for the encapsulation and delivery of therapeutic molecules, such as: RNA, DNA, CRISPR-Cas9, small molecules, proteins and peptides. The company supports customers on each step of the project, including quality control, analytics, bioassay, regulatory support, warehousing and project management.
Symbiosis
Symbiosis Pharmaceutical Services is a contract manufacturing organisation (CMO) specialising in the GMP manufacture and sterile fill/finish of vials for clinical trials and commercial supply. Regulatory compliance, technical capability and operational flexibility are at its core. Manufacturing from a purpose-built FDA inspected and MHRA-licensed facility, the CMO can handle products that require aseptic liquid filling and lyophilisation for a range of complex biologics, viral vectors for use in gene therapies and small molecule drugs. Offering fast access to manufacturing slots and accelerated release of drug product, Symbiosis is primed to meet demand for small-scale, fast-turnaround drug product sterile manufacturing. | Symbiosis is a global, client-focused, contract manufacturing organisation (CMO) offering GMP aseptic manufacture for clinical trials through to commercial supply. Utilising batch strategies closely aligned with the latest regulatory framework, Symbiosis empowers drug developers to meet their project milestones through rapid access to fill-finish slots. Our purpose-built, FDA-inspected and MHRA-licensed manufacturing suites are designed with cytotoxic APIs in mind. Working with liquid and lyophilised formulations, our expert in-house team has over ten years of experience in taking a wide range of from drug substances to QP release e.g. mAbs, vaccines, small molecules, ADCs, ATMPs, etc. As trusted partners, Symbiosis are dedicated to supporting our clients facilitate safe, life-saving injectable drug therapies, without delay. Get in touch to begin your fill-finish program. | Symbiosis is a global contract manufacturing organisation (CMO) offering drug product GMP aseptic manufacture for clinical trials through to commercial supply. Closely aligned with the latest regulatory framework including Annex 1 and BSL-2, Symbiosis empowers drug developers to meet their project milestones through rapid access to fill-finish slots. Our purpose-built, FDA-inspected and MHRA-licensed manufacturing suites are designed to accommodate cytotoxic APIs. Working with liquid and lyophilised formulations, our expert in-house team handle a range of modalities from drug substance to QP release e.g. mAbs, vaccines, small molecules, ADCs, ATMPs, etc. As trusted partners, Symbiosis are dedicated to supporting our clients facilitate safe, life-saving injectable drug therapies, without delay.
STC Biologics
WHO ARE WE STC Biologics, Inc is a fully integrated CDMO located in Newton MA, USA that provides full CMC Services and Consulting for drug developrs to advance their biologic products from discovery to commercialization. Founded in 2009, the Team brings deep expertise in biologics drug development and global regulatory approvals from a “who’s who” list of companies like Genentech, Novartis, Shire, EMD Serono, Lonza, Alexion and Merrimack. The holistic view of drug development with the integration of biology into CMC development, and the cross-training of its scientists in those diverse fields is what makes STC unique in its ability to expedite timelines to the clinic. STC strives to REALIZE “SPEED TO CLINIC” THROUGH INTEGRATED PRODUCT DEVELOPMENT, TECHNICAL RIGOR, AND FLEXIBILITY. CORE COMPETENCIES STC Biologics’ core competencies center on biologics drug development starting from cell line generation for high expression levels, process, analytical and formulation development to GMP production. The technical and regulatory know-how at STC Biologics enables integrated product development planning and successful maneuvering through inevitable development challenges. STRATEGY STC has established its reputation as a flexible organization that clients can turn to for accelerated low-cost programs through our Speed-To-Clinic Platform™, or for custom development when template processes don’t meet the needs of complex products. STC introduced Speed-To-Clinic Platform™ for MAbs starting from royalty free Cell Line Development directly to cGMP Manufacturing and released Drug Substance, all within a 12-month cycle – even for challenging proteins. DEVELOPMENT & COMMERCIALIZATION Having written over 8 BLAs, dozens of INDs, & 20 comparability protocols & supplemented by experience in the life cycle management of 5 approved biologics, our management team is uniquely positioned to guide our clients to develop an integrated CMC plan tied to preclinical & clinical development with an eye on regulatory expectations. During the last five years, we have advanced our first biosimilar product, STC101, from concept to clinical development in Europe under the EMA guidance. We have also helped our clients overcome complex process & analytical challenges through rigorous & customized efforts. Why work with STC? Executive Team with over 100 years in the industry; Over 100 assays developed; 18 INDs filed; 8 BLAs filed. By Phase With experience in all phases of product development for a range of biotherapeutics and commitment to advance the products through development, STC Biologics is your preferred strategic partner. We take pride in our ability to become an expert on your product, to go above and beyond in order to drive it through various stages of product development and ultimately successfully tell the story of your product in regulatory submissions. By Service The time and cost savings of an integrated approach to developing products, not constrained by the boundaries of different departments, has been realized in smart cross-functional organizations. STC Biologics, Inc. is founded on such boundary-less merge of disciplines, as the knowledge of biology, process development, analytics, formulation, and regulatory sciences is in one team body. Our pride in technical rigor, perseverance, critical thinking, and multidisciplinary collaborative work ethics bring agile resolution to technical hurdles and nimble development of products. At STC Biologics, we specialize in providing end-to-end solutions for biopharmaceutical development and manufacturing. Our team of experts is dedicated to delivering high-quality and innovative services, including: • Cell Line Development: Customizable and efficient cell line development tailored to meet your specific requirements – high-titer results o For complex molecules (e.g. multi-specifics): developability, manufacturability, high-order analytics • Process Development: Comprehensive process development, optimization, and scale-up for both upstream and downstream processes. • Analytical Services: Robust analytical testing and characterization to ensure product quality and compliance with regulatory standards. • Formulation development: Complex, sensitive and high concentration formulations • cGMP Manufacturing: State-of-the-art cGMP manufacturing facilities for clinical production. • Bioconjugation chemistry for: ADCs, radiopharmaceuticals, Oligos Leadership: Dr. Magdalena Leszczyniecka, PhD. MBA. President and CEO of STC Biologics Email: magda@stcbiologics.com Magdalena founded STC Biologics Inc. in 2009 with a goal to bring biosimilar products to patients who cannot afford branded equivalents. Since 2009, STC has worked on four biosimilar antibody products, some being developed in-house and others for STC’s partners. As a leader in the biosimilar sector, she presents at key biosimilar business conferences each year, is an strategy advisor to Sectoral Asset Management and consults on biosimilars for Coleman Research (a company focused on providing market research for buy-side investors). She has three patents relating to biosimilar product optimization, covering methods to achieve fingerprint-like similarity in product quality. STC’s main goal is to bring a biosimilar product to the market with reduced burden of clinical trials by providing fingerprint analytical data on product similarity. Magdalena has a broad drug development experience in small molecules and various biologics including IgG1, IgG4, two Fc fusion proteins, antibody single chains, and antibody targeted liposomal formulations. She gained start up experience prior to STC working for venture capital firms: Flagship Ventures and Atlas Ventures. She has led the development of MM-121 and anti-HER3 antibody programs at Merrimack Pharmaceuticals. In 2002, she started her scientific career at Novartis Pharmaceuticals as a project leader for two oncology development products. She received her Ph.D. from a joined program between Columbia University and NYU, an MBA from Babson College, and a B.S in Biochemistry from Rutgers University. Dr. Zahra Shahrokh, PhD. Chief Development Officer at STC Biologics Email: zshahrokh@stcbiologics.com Zahra brings a broad experience in biotechnology product development with a track record in global regulatory approvals of 5 biological products (Replagal, Elaprase, Dynepo, VIPRIV, Firazyr) and in the clinical development of dozens of novel biologics. She has more than 25 years experience in biopharmaceutical development: 10 years at Genentech as Senior Group Leader in Pharmaceutical Development and CMC team leader, 10 years at Shire HGT as both Head of Pharmaceutical and Analytical Development and then Head of CMC Program Management, followed by another 4.5 years as a CMC consultant. At STC Biologics, she provides strategic and technical leadership for the development of internal and client products, including biosimilars, antibody based products, viral products, and targeted liposomal products. At Shire, she built organizational capabilities throughout the company’s growth phase from a start-up company (known as TKT) towards a multi-billion dollar commercial organization. She had oversight of formulation & drug product manufacturing process development, tech transfer, analytical development & process development analytical operations, specifications development & comparability, product characterization, and clinical GMP testing & stability programs. Furthermore, she held roles such as Chair of Quality Standards Committee and Program Executive for the CNS projects, at Shire. She designed and instituted Shire’s first CMC Program Management system to transform the effectiveness of product development teams. She was a CMC representative in regulatory agency meetings, formulated responses to questions, and managed implementing CMC strategy within the department. She had technical and leadership roles at Genentech’s Pharmaceutical R&D department, and prior to that at Scios Nova, where she drove pharmaceutical development of several classes of biologics and small molecules. Zahra has a post-doctoral fellowship at UCSF, PhD in Biophysics from University of California, Berkeley and a dual BA degree in Chemistry and Physics from University of Pennsylvania, Philadelphia. She holds several pharmaceutical patents and over 60 papers and invited presentations. For the past 10 year she has been an invited lecturer in Biotechnology at the University of Kansas, Pharmaceutical Chemistry department, and an active member of the Organizing Committee for WCBP and “CMC Strategy Forum” that brings together regulators and biotech industry to present and debate current topics in product development in the context of globalization and regulatory sciences.
Solvias
Solvias helps innovative companies advance their path to commercialization with CMC analytical solutions powered by deep scientific expertise and a relentless focus on our customers’ success. With years of expertise in cell & gene therapy, biologics and small molecules, and an offering that spans the drug development process, our talented subject matter experts have the know-how, creativity, and tenacity to solve even the most complex analytical challenges.
Simtra BioPharma Solutions
As the premier, independently owned CDMO with more than 65 years of sterile injectable manufacturing expertise, Simtra BioPharma Solutions delivers advanced cGMP sterile fill and finish to the highest standard in the industry. Our focused approach is backed by technical rigor, collaborative integrations, and a future-forward mindset designed to support our customers strategic objectives. Biotech and pharmaceutical companies partner with Simtra when they need to take their molecule to market, whether launching their innovation globally, improving their formulation, or proactively mitigating risk to help grow their business. Our teams of tenured experts deliver tailored, flexible solutions to help customers consistently fulfill their product goals at the highest quality, so they get in the hands of the patients who need them most.
Shanghai Taichu Biotechnology Co., Ltd.
Taichu group was founded in 2020, providing contract research, development and manufacturing services to pharmaceutical and biotech companies. Our service platforms include early discovery and design of complex antibodies such as multispecific antibodies, nanobodies, fusion proteins etc. Our GLP- and AAALAC- certified animal facility provides preclinical studies (PK/PD), safety evaluation (Toxicology) for a various modality of drug candidates, such as small molecules, biologics, ADC, CGT products, and RNAi, ASO, mRNA molecules. For development and manufacturing of complex antibodies, our CDMO (Tarlead) has experienced teams, well-established laboratories and facility for process development, drug substance production and drug product manufacturing, ready to meet your needs and timelines. | Taichu Group is a biotechology enterprise with a core advantage in “CRO+CDMO integrated services”, providing end-to-end solutions for global innovative drug development from early discovery through preclinical research. Headquartered in Shanghai’s Lingang Special Area, the Group operates through its subsidiaries: Taichu Bio (Pre-Clinical Research), AceMab Ltd (Antibody Discovery & Design), Tarlead Biologics (Biologics Development & Manufacturing), TJR Bio (Nucleic Acid Drug Process & Manufacturing), and Taichu (Shenzhen) (Innovative Therapeutic Development Advisory). Guided by the philosophy “Advocate of Ethics and Integrity, Quest for Verity”, we streamline R&D workflows and accelerate therapeutic advancement for global partners. Our synergistic service model bridges key gaps between discovery and commercialization, reinforcing our role as a strategic enabler in the biopharmaceutical innovation value chain.